ProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smart™ Test in Detecting Esophageal Cancer

BE-Smart represents a significant advance in diagnosis and management of Esophageal disease that affects an estimated 60 million people in the United States

Study shows >95% success rate, validating BE-Smart for use with esophageal brush cytology.

Read more at globenewswire.com